COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to use approximately $25 million to ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Arrowhead ...
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...
As a market leader, Rocket Companies rebranding comes in the foreground of several court battles and fluctuating earnings ...
Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...
Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...
In his confirmation hearing, Robert F. Kennedy Jr told Bernie Sanders that he opposes health care as a human right. His ...
President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...
LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback